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Abstract
Three new proteins, FmhA, FmhB and FmhC, with significant identities to FemA and FemB were identified in the
Staphylococcus aureus (ATCC 55748) genome database. They were mapped to the SmaI-C, SmaI-H and SmaI-A fragments of
the S. aureus 8325 chromosome, respectively. Whereas insertional inactivation of fmhA and fmhC had no effects on growth,
antibiotic susceptibility, lysostaphin resistance, or peptidoglycan composition of the strains, fmhB could not be inactivated,
strongly suggesting that fmhB may be an essential gene. As deduced from the functions of FemA and FemB which are involved
in the synthesis of the peptidoglycan pentaglycine interpeptide, FmhB may be a candidate for the postulated FemX thought to
add the first glycine to the nascent interpeptide. z 1999 Federation of European Microbiological Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
The acquisition of the additional, low a⁄nity pen-
icillin binding protein PBP2P (PBP2a) is the prereq-
uisite for methicillin resistance in Staphylococcus aur-
eus. In the presence of L-lactams, PBP2P is thought
to substitute for the cell’s normal PBP functions. In
addition to PBP2P, the level of methicillin resistance
(a strain-speci¢c characteristic) also depends on fem
or aux factors which are part of the genome of sus-
ceptible and resistant strains. Most of these factors
have functions in, or a¡ect indirectly, cell wall me-
tabolism (reviewed in [1]). The highest impact on
methicillin resistance is shown by the femAB operon,
whose inactivation abolishes methicillin resistance
but still allows PBP2P production [2]. FemA and
FemB are proteins involved in the formation of the
peptidoglycan pentaglycine interpeptide. They pre-
sumably catalyze and/or control the incorporation
of Gly2-Gly3 (FemA), and Gly4-Gly5 (FemB). A
third factor (FemX) responsible for the attachment
of the ¢rst glycine residue to the O-amino group of
lysine of the nascent interpeptide has been postulated
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[3]. Because of similar functions, FemX was specu-
lated to have some sequence similarity with FemA
and FemB. Moreover, since femAB inactivation also
strongly impairs growth, femX was thought to have
an even greater impact on the cell’s viability and to
be a lethal target. Low stringency hybridizations in-
dicated that here may be sequences with some ho-
mology to femA and femB in S. aureus (B. Berger-
Baºchi, unpublished results). We searched the S. aur-
eus genome for femAB-like genes and identi¢ed a
candidate sequence for femX that seems to be essen-
tial for S. aureus.
2. Materials and methods
2.1. Strains, growth conditions and resistance tests
Protein sequence searches were done on a data-
base derived from the genome sequence of a methi-
cillin-resistant (Mcr) clinical isolate of S. aureus
(ATCC 55748). Gene disruption experiments we
done in Mcr S. aureus BB270, a derivative of
NCTC 8325 [2]. Cells were grown in LB broth at
37‡C. Hypertonic media were used when mentioned:
medium 1 consisted of 3.7% BHI supplemented with
5% NaCl, 5% sucrose, 0.5% yeast extract, and 0.5%
BSA [4] ; medium 2 consisted of 2% BHI supple-
mented with 0.5 M sodium succinate. Minimal inhib-
itory concentrations (MICs) were determined by mi-
crobroth dilution [5] or with E-strips (Solna, Sweden,
[6]) on LB plates containing the appropriate antibi-
otic where needed. The MIC of lysostaphin (AMBI,
Trowbridge, UK) was determined by microbroth di-
lution at 35‡C in LB broth supplemented with an
antibiotic where required.
2.2. Plasmid preparation, transduction and
transformation
For DNA manipulations, the recommendation of
the enzyme manufacturer and the protocols of Ma-
niatis et al. [7] were followed. The modi¢cations
needed for lysing S. aureus by lysostaphin have
been described earlier [8]. Preparation and separation
of chromosomal SmaI digests by pulsed ¢eld gel elec-
trophoresis was as described by Wada et al. [9]. Re-
combinant plasmids were ¢rst electroporated in re-
striction-negative, modi¢cation-pro¢cient RN4220
and then transferred by phage 80K mediated trans-
ductions into S. aureus BB270 as described earlier
[2].
2.3. Gene disruption
For gene disruption experiments, internal frag-
ments (V650^700 bp) of the fmh genes were ampli-
¢ed by PCR and cloned into the multiple cloning site
of the Escherichia coli- S. aureus shuttle vector pOX7
[10] which carries an erythromycin resistance marker
for selection and is temperature-sensitive (ts) for rep-
lication in S. aureus and ampicillin-resistant in E.
coli. The following primers were used for amplifying
the internal fragments from strain BB270: MT3 (5P-
GGGGATCCGTTGATTTAAAAGGCGATGTG-
C-3P) and MT4 (5P-GCCTGCAGAATTTGTTCTA-
TTGTATTGTCG-3P) for fmhA, MT15 (5P-GC-
CTGCAGCAGAAACAAAGAAATTAACTGG-3P)
and MT16 (5P-GCCTGCAGATTTAGCTATTTC-
GGCATGAAG-3P) for fmhB, and MT5 (5P-CCG-
GATCCCAGTGATAGTAAAGATGCTAGG-3P)
and MT6 (5P-GCCTGCAGATCCGCCTCATTAC-
TAAAGACG-3P) for fmhC. After cloning in Esche-
richia coli the plasmids were electroporated into re-
striction-negative S. aureus RN4220 and subse-
quently transduced into the Mcr strain S. aureus
BB270. To promote chromosomal integration of
the plasmid, strains were grown in LB containing
20 Wg erythromycin ml31 at 30‡C to stationary
phase. The culture was diluted 1:200 into fresh me-
dium, incubated at 30‡C for 3 h, and appropriate
dilutions were spread on LB agar plates containing
10 Wg erythromycin ml31 and incubated at 42‡C.
Furthermore, we tried to inactivate fmhB using a
double crossover strategy by replacing an internal
V350-bp fragment of fmhB by an ermB cassette.
The N-terminal part spanning the promoter and
ribosome binding site and the C-terminal part in-
cluding the stop codon and beyond of fmhB were
ampli¢ed with MT19 (5P-GCGAATTCACACGA-
AACATAGATATAAAATG-3P)/MT20 (5P-GCGG-
TACCCCCAGTGATTTTCATTAATTC-3P), and
MT21 (5P-CCGGATCCGCAAAATATGATTAAT-
GATGC-3P)/MT22 (5P-CGCTCTAGACCCAAAG-
AAAATTGTAATAGC-3P), respectively, yielding
approximately 600-nt fragments that were cloned to
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the left and right of the ermB cassette into the ts E.
coli-S. aureus shuttle vector pBT2 [11] which is chlor-
amphenicol-resistant in S. aureus. Selection for inte-
gration of the ermB cassette by double crossovers in
the chromosome of strain BB270 was by sequential
dilution and growth in the presence of 2.5 Wg ml31
erythromycin at the nonpermissive temperature of
42‡C followed by one growth cycle in the absence
of erythromycin and a ¢nal plating on erythromycin
plates as described by Bruºckner [11]. The colonies
were tested for loss of the plasmid by replica plating
on LB agar plates containing 10 Wg chloramphenicol
ml31 and 2.5 Wg erythromycin ml31. A double cross-
over event should yield chloramphenicol-sensitive
and erythromycin-resistant colonies. As alternative
selection media, hypertonic media 1 and 2 were
used to stabilize the putative deleterious mutants;
or lysostaphin, a glycylglycine endopeptidase, was
added at a concentration of 8 Wg ml31 to the growth
medium to promote and select mutants with altered
or shortened pentaglycine interpeptides, where indi-
cated.
2.4. Cell wall composition
The peptidoglycan was isolated and digested with
muramidase into muropeptides as described [2]. Re-
duced muropeptides were separated by reverse phase
HPLC [12]. Strains carrying inactivated fmhA or
fmhC were grown at 43‡C in BHI to prevent excision
of the plasmid. The parental strain was grown under
the same conditions without erythromycin.
3. Results
3.1. Identi¢cation and characterization of FmhA,
FmhB, and FmhC
The FemA and FemB protein sequences were used
to search a protein database derived from the ge-
nome sequence of the Mcr clinical isolate of S. aur-
eus (ATCC 55748). Three new proteins (Fem homo-
logues: FmhA, FmhB, and FmhC) of similar sizes
(416, 421, and 414 aa, respectively) and signi¢cant
sequence identities were identi¢ed (Table 1). Se-
quence comparisons with the known staphylococcal
FemAB-like proteins showed that FmhA and FmhC
had stronger homology to each other (59% sequence
identity) than to either FemA or FemB (Table 1).
Furthermore, FmhA and FmhC were even more
similar to Epr [13] and Lif [14], both known to direct
serine incorporation into the interpeptide and thus
protect the cell wall against digestion by glycylgly-
cine endopeptidases such as lysostaphin or Ale-1.
FmhB had the lowest identity to any of these factors.
Similar low identities were shown by the non-staph-
ylococcal FemAB-like factors Zif, the zoocin immun-
ity factor [15], and a FemA-like protein reported in
Borrelia burgdorferi (accession number SPTREMBL
O51533), both of unknown function. The 5P proxi-
mal sequence of fmhB has very good agreement with
Gram-positive consensus promoter sequences [16]
and RBS, whereas no such high homologies could
be found in front of fmhA. fmhC (synonym eprh
[17]) is preceded by lytN encoding a putative
FEMSLE 8580 5-2-99
Table 1
Amino acid identities of the Fmh factors to other FemAB-like factors
FemA (Sa) FemA (Se) FemB (Sa) FemB (Se) Epr Lif FmhA FmhC FmhB
FemA (Sa) 100
FemA (Se) 81 100
FemB (Sa) 40 39 100
FemB (Se) 40 39 87 100
Epr 40 41 38 38 100
Lif 41 43 39 39 70 100
FmhA 43 41 40 41 62 64 100
FmhC 37 38 37 37 58 57 59 100
FmhB 27 26 26 25 23 23 25 21 100
The sequences of FmhA, FmhB and FmhC can be obtained from GenBank under accession numbers AF106849, AF106850, and AF106851.
Sa, S. aureus ; Se, Staphylococcus epidermidis. FemA (Se), accession number U23713; FemB (Se), accession number U23714. FmhC is nearly
identical (s 99.5% identity at the nt level) to the recently published Eprh [17]. epr, lysostaphin endopeptidase resistance gene from Staph-
ylococcus capitis [13] ; Lif, lysostaphin immunity factor from Staphylococcus simulans biovar staphylolyticus [14].
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autolysin, and may be cotranscribed with that
gene.
3.2. Gene disruption of fmhA and fmhC
Using the fmhA, fmhB and fmhC sequences, inter-
nal fragments of the corresponding genes were am-
pli¢ed from the laboratory strain BB270 and se-
quenced. The ampli¢cates showed less than 1%
nucleotide substitutions in the primary sequence of
which approximately every fourth nt substitution led
to a conservative exchange in the deduced amino
acid sequence compared to ATCC 55748. With these
fragments, fmhA was mapped by Southern blot on
the chromosomal SmaI-C, fmhB on the SmaI-H and
fmhC on the SmaI-A fragment of BB270 (data not
shown).
These fragments cloned into pOX7 were used for
insertional inactivation of the corresponding genes.
Disruptants of fmhA and fmhC were obtained with a
frequency of 1033^1034. Analysis of their chromoso-
mal DNA by PCR con¢rmed the integration of the
ts plasmids at the expected sites and the absence of
an intact wild-type gene of fmhA and fmhC (not
shown). To prevent potential plasmid excision, these
strains were maintained and grown at the nonper-
missive temperature.
By the same approach no viable disruptants were
obtained with the fmhB insert, nor did we obtain any
integrations using the alternative ts vector pTS1 with
a 300 nt long internal fmhB insert. Allele replace-
ment by the double crossover approach, which
should have substituted part of fmhB by an erythro-
mycin resistance cassette, yielded only erythromycin-
and chloramphenicol-resistant mutants due to a sin-
gle crossover resulting in an interrupted and an in-
tact gene copy of fmhB. No loss of chloramphenicol
resistance, which would indicate a putative double
crossover event, was ever observed among over
1000 colonies tested. In a second approach, to pro-
tect putative osmotically fragile fmhB mutants, the
growth medium was substituted in the selection
process with hypertonic medium, however, resulting
again in no plasmid excision. Addition of 8 Wg lyso-
staphin ml31 also failed to result in double cross-
overs, although lysostaphin is known to select for
femAB mutants with shortened pentaglycine inter-
peptides [2]. Since disruption of fmhB proved impos-
sible by these various approaches, and was well be-
low the knockout frequency of this method reported
by Bruºckner [11] that lies in the range of 1% to
s 50%, whereas fmhA and fmhC disruptions were
functional, we postulate that fmhB is essential for
S. aureus.
3.3. Antibiotic resistance and cell wall composition
The inactivation of femhA or fmhC had no e¡ects
on the resistance levels at 43‡C towards vancomycin
(MIC 1.5 Wg ml31), teicoplanin (MIC 0.5 Wg ml31),
oxacillin (MIC 0.5 Wg ml31), lysostaphin (MIC 0.125
Wg ml31), or methicillin (MIC 1.5 Wg ml31) com-
pared to those of the parental strain BB270 at the
same temperature. The MICs of methicillin and of
oxacillin of strain BB270 at 37‡C were 8 and s 256,
respectively, as expected. Likewise peptidoglycan
composition was identical in the parental and fmhA
or fmhC mutant strains. The elevated growth tem-
perature used to prevent plasmid excision in the mu-
tants led to an increased amount of monomeric mur-
opeptides in the cell wall. Most prominent were the
unsubstituted muropeptides without a glycine side
chain (Table 2). The increase in these muropeptides
was also observed in the parental strain when cul-
tured at 43‡C. It caused a slight reduction in overall
crosslinking.
4. Discussion
The two femAB-like sequences fmhA and fmhC are
of lesser importance and their activity and function
are still unknown. They have higher identities to the
serine-incorporating Lif and Epr than to the glycine-
incorporating FemA and FemB. Interestingly, fmhC
FEMSLE 8580 5-2-99
Table 2
Relative amounts of muropeptides in parent and mutant strains
at di¡erent growth temperatures
Strain (growth temperature) Gly0 Gly5 Crosslinkage (%)
BB270 (37‡C) 1 1 75.3
BB270 (42‡C) 5.9 2.6 63.9
fmhA (42‡C) 7.5 2.4 66.0
fmhC (42‡C) 6.0 2.3 63.9
Gly0, unsubstituted muropeptide; Gly5, pentaglycine muropeptide,
for structure see [12].
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is associated with a autolysin-like gene, similar to lif
and epr. Since their inactivation had apparently no
e¡ects on growth, cell wall composition or resistance,
and since in this S. aureus strain no measurable ser-
ine substitutions were found in the pentaglycine in-
terpeptide, they may be remnants of FemAB-like
proteins, with speci¢city for amino acids other than
glycine, such as serine or alanine which sometimes
occur at very low frequencies in the interpeptide of
some S. aureus strains, but generally more frequently
in other staphylococcal species [18]. In contrast,
FmhB, the most distantly related of the three new
factors, seemed essential for growth, as was also re-
cently observed by Tang et al. [19]. Because of its
relatedness to FemA and FemB and its apparent
essentiality, FmhB may be the factor FemX pre-
dicted to be involved in the addition of the ¢rst
glycine to the peptidoglycan O-L-lysine [3]. It may
also correspond to the femAB-like factor identi¢ed
in a murine model of bacteremia shown to be re-
quired for virulence, as were also femA and femB
[20].
Increased amounts of monomeric muropeptides
were observed at elevated temperatures in parent
and mutant strains. Although the amount of unsub-
stituted muropeptides increased six- to sevenfold, it
is important to note that this muropeptide is usually
a minor component of the staphylococcal cell wall
representing only 0.2% of all muropeptides. Thus the
resulting reduction in crosslinking comprised only
10%, presumably not enough to account for the
drastic drop in methicillin resistance at elevated tem-
peratures. Nevertheless this observation may indicate
that the FemX, FemA, and FemB proteins involved
in the interpeptide biosynthesis and the PBPs cata-
lyzing the crosslinking may be less active at higher
temperatures.
FemAB-like factors may form a new group of
proteins involved in non-ribosomal protein biosyn-
thesis. They can be classi¢ed into four groups [1]: (i)
the Lif- and Epr-containing group that may also in-
tegrate serine, to which FmhA and FmhC likely be-
long; (ii) FemB and (iii) FemA-like factors, which
both integrate glycine residues at distinct positions
along the interpeptide, and (iv) the more distant
FmhB of unknown function.
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